SCHEMBL17923649

SCHEMBL17923649

Brc1ccc2c(c1)-c1cc(-c3ccccc3-c3ccccc3)ccc1C21c2ccccc2-c2ccccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 3/20 0.40
▸ MAPK1 P28482 3/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ PTGDR2 Q9Y5Y4 1/20 0.37
▸ KDM4E B2RXH2 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ PTPRC P08575 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ OPRK1 P41145 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ TP53 P04637 1/20 0.35
▸ GLA P06280 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ TDP1 Q9NUW8 2/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ RARB P10826 1/20 0.35
▸ RARG P13631 1/20 0.35
▸ RXRA P19793 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17923675 0.94 PDK2 (0.44) PDK2MAPK1ALDH1A1PTGDR2KDM4E
SCHEMBL22797311 0.92 MAPK1 (0.45) PDK2MAPK1ALDH1A1PTGDR2KDM4E
SCHEMBL26369373 0.92 MAPK1 (0.45) PDK2MAPK1ALDH1A1PTGDR2KDM4E
SCHEMBL5763937 0.87 PDK2 (0.46) PDK2MAPK1ALDH1A1PTGDR2KDM4E
SCHEMBL12469930 0.86 PDK2 (0.49) PDK2MAPK1KDM4ELMNAMAPT
SCHEMBL31396643 0.86 PDK2 (0.49) PDK2MAPK1KDM4ELMNAMAPT
SCHEMBL29603046 0.86 PDK2 (0.49) PDK2MAPK1KDM4ELMNAMAPT
SCHEMBL45620 0.86 PDK2 (0.49) PDK2MAPK1KDM4ELMNAMAPT
SCHEMBL16628918 0.86 PDK2 (0.49) PDK2MAPK1KDM4ELMNAMAPT
SCHEMBL31396648 0.86 PDK2 (0.49) PDK2MAPK1KDM4ELMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160211456-A1 PHENANTHRO[9,10-b]TETRAPHENYLENE DERIVATIVE AND USE THEREOF LUMINESCENCE TECHNOLOGY CORP. 2016-07-21 — — US disclosed
US-20160211456-A1 PHENANTHRO[9,10-b]TETRAPHENYLENE DERIVATIVE AND USE THEREOF LUMINESCENCE TECHNOLOGY CORP. 2016-07-21 — — US disclosed
US-20160211456-A1 PHENANTHRO[9,10-b]TETRAPHENYLENE DERIVATIVE AND USE THEREOF LUMINESCENCE TECHNOLOGY CORP. 2016-07-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160211456-A1 PHENANTHRO[9,10-b]TETRAPHENYLENE DERIVATIVE AND USE THEREOF POP1, TERB1, AP2B1 PDK2 2688/4885MAPK1 2317/4885ALDH1A1 2052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback